Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.50% | 26.98% | 2.86% | 0.00% | -13.12% |
| Total Depreciation and Amortization | 0.68% | -0.68% | 1.38% | 2.11% | -0.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 255.81% | -51.69% | 709.09% | -92.90% | 142.19% |
| Change in Net Operating Assets | -101.14% | 141.90% | -428.13% | 204.76% | -61.82% |
| Cash from Operations | 2.35% | 114.75% | -40.22% | -17.41% | 3.49% |
| Capital Expenditure | -20.29% | -21.05% | 27.85% | -9.72% | -33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 24.00% | -47.06% | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.00% | -- | -- | 173.91% | -2,400.00% |
| Cash from Investing | -26.12% | 11.84% | 20.42% | 4.98% | -62.10% |
| Total Debt Issued | -100.00% | -- | -- | -100.00% | -94.59% |
| Total Debt Repaid | 99.40% | -49,900.00% | 0.00% | 90.00% | 97.51% |
| Issuance of Common Stock | 68.75% | -75.38% | 261.11% | -5.26% | 46.15% |
| Repurchase of Common Stock | -47.57% | -178.38% | 87.71% | -98.03% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.04% | -9.09% | 2.22% | -1.12% | 1.11% |
| Other Financing Activities | -20.00% | 56.04% | -204.60% | 448.00% | -- |
| Cash from Financing | -18.34% | -50.66% | 47.04% | -16.19% | 15.70% |
| Foreign Exchange rate Adjustments | 100.00% | 0.00% | -200.00% | 150.00% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.61% | 962.96% | -125.00% | -110.62% | -13.74% |